Coronary Heart Disease Clinical Trial
Official title:
Secondary Prevention in Uppsala Primary Health Care After Myocardial Infarction, Coronary Artery CABG and PCI. Secondary Prevention After CHD (SUPRIM).
The purpose of this study is to determine the possible preventive effect of behavioural modification versus standard treatment after hospital discharge in CHD patients.
According to a recent Cochrane report there is little evidence so far that psychological
interventions affected total or cardiac mortality, but had a reduction in the number of
non-fatal recurrent AMI and small effect on anxiety and depression.
The subjects were recruited among consecutive patients discharged from Uppsala University
Hospital. Inclusion criteria were age 75 years or younger, discharged from the hospital
after a myocardial infarction (AMI) or percutaneous coronary intervention (PCI) or coronary
artery bypass grafting (CABG), living in the hospital primary catchment area, referred back
to the general practitioner (GP) within one year after the hospital admission, not having
previously participated in similar programs, being Swedish speaking, being willing to
participate in the study, and accepting the random group allocation to be. All subjects
fulfilling the inclusion criteria were informed about the study during the first outpatient
visit to the hospital two weeks after discharge. During a visit to the cardiology outpatient
department three months after discharge the informed subjects were formally invited to
participate and verbal informed consent was obtained, standard requirement at the time. A
written invitation letter to a baseline examination in the study was then mailed to the
subjects and those who accepted the invitation were eventually included. The recruitment
period lasted from may 1996 to august 2001 and the follow-up data collection was completed
in 2008.
At the end of the recruitment period 812 consecutive patients had been considered for
inclusion, of which 302 did not fulfill the inclusion criteria, and 148 subjects declined to
participate, in most cases because of long distance from home to the hospital or lack of
time. The remaining 362 subjects (71.0% of eligible cases), 85 (23%) women, 277 (77%) men
gave informed consent to participation, of whom 185 (51.1%) had been admitted for an AMI,
122 (33.7%) for a CABG, and 55 (15.2%) for a PCI. Seventy-one AMI subjects had a PCI
performed during the course of events and three had a CABG. At the time of the study more
than 95% of the Swedish population in these age groups was Caucasians and about 90% were
native Swedes.
The group allocation was based on the SAS "ranuni" function that provides random numbers
with equal probability. The randomization procedure was based on pre-prepared sealed
envelopes with a serial number on the outside and containing a paper sheet with the group
allocation on the front side and a blinding print on the back to eliminate the possibility
to read the group allocation sheet from the outside of the envelope. The envelopes were kept
in sorted ascending serial number order in a safe. After inclusion of a subject the study
monitor (the only person with access to the randomization envelopes and information) drew
the next envelope in order and inserted the allocation paper sheet in the study protocol. Of
those included, 192 were allocated to behavioral intervention and 170 to the reference
group. The included subjects were informed about the group allocation after the baseline
measurement.The subjects received an invitation letter for a first (baseline) examination
and a first postal questionnaire. The procedure was repeated at the 6th, 12th, 18th and 24th
month after baseline. The examination included anthropometry (height, weight and sagittal
diameter), and blood pressure measurement, and blood sampling for blood lipids.
Information on marital status, educational level, smoking habits, job status (including
retirement or on sick leave), social background and lifestyle factors was obtained by
questionnaire.
The Gothenburg Quality of Life Instrument, previously validated and used in many studies,
was used to measure quality-of-life aspects. Information on medical history until the
baseline measurement was obtained from the baseline questionnaire. The subjects were asked
whether they had experienced angina pectoris, hypertension, hyperlipemia, congestive heart
failure, stroke, peripheral artery disease, diabetes, or asthma/congestive pulmonary
disease. Responses were given as "yes" or "no".
Hospital admission data were obtained by linking the study data set to the National Hospital
Discharge Register and the National Cause of Death Register to include non-fatal as well as
fatal events. The record linkage was based on the unique personal identification number
(PIN) given to all Swedish residents at birth or immigration and used in all official
registers, including the population register. The PIN is based on year, month and day of
birth, and a four-digit serial number. The second last serial number digit refers to subject
sex and the last digit is a control digit, by which the correctness of the PIN easily can be
checked and if necessary corrected against the population register. Data from the National
Hospital Discharge Register included all hospital admissions from 1971 until 31 December
2006.
Survival data were obtained from the Cause of Death Registry, including all deaths in the
study population until 31 December 2006. The overall autopsy rate was 23%, and the autopsy
rate among those who had a first fatal cardiovascular event as outcome in the trial was 50%.
Diagnoses in the Hospital Discharge Register and the Cause of Death Register were coded
according to the International Classification of Diseases (ICD). Cardiovascular disease was
defined as ICD-8 codes (until 1986) and ICD-9 codes (1987-1996) 401-459, and ICD-10 codes
(from 1997 on) I00-I99. Acute myocardial infarction was defined as ICD-8 code 410, ICD-9
code 410, and ICD-10 code I21-I22.
Based on these data the number of AMIs per subject prior to baseline was identified. In
addition, all death irrespective of its cause, first cardiovascular disease event, fatal or
non-fatal was identified, as well as the first AMI post baseline.
Subjects entered the intervention program within a year after the index coronary event. The
intervention was based on cognitive behavioral therapy focused on stress management aimed to
help CHD patients cope with stress and reduce experience of daily stress, time deadlines and
hostility. For this purpose they were randomized to behavioral intervention or no behavioral
intervention (usual care). The intervention, cognitive behavioral therapy (CBT), adapted to
CHD patients, was performed in group-sessions, including 5-8 participants, separate groups
for women and men, altogether 20 two-hour sessions per group during one year. An experienced
psychologist, expert in CHD patient CBT, formed a team of trained psychologists and nurses,
and together they performed the sessions. To secure continuity, all groups were treated by
the same group leader. Attendance rate in sessions was monitored and the adherence to the
program was excellent. Median attendance rate was 85%, and less than 5% attended less than
50% of the sessions. The program had specific goals and 5 key components; education,
self-monitoring, skills training, cognitive restructuring and spiritual development.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Completed |
NCT05088291 -
Application of a New X-ray Protective Device in Coronary Interventional Therapy
|
||
Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Not yet recruiting |
NCT04995159 -
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
|
N/A | |
Recruiting |
NCT02967718 -
Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome
|
N/A | |
Completed |
NCT02888652 -
Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
|
||
Terminated |
NCT02045134 -
Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery
|
N/A | |
Completed |
NCT02163044 -
The Hellenic Postprandial Lipemia Study (HPLS)
|
||
Active, not recruiting |
NCT02244853 -
Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
|
N/A | |
Completed |
NCT02440893 -
Understanding the Effect of Metformin on Corus CAD (or ASGES)
|
||
Completed |
NCT01826552 -
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
|
Phase 4 | |
Completed |
NCT01920009 -
Impact of Motivational Interviews Within Pharmacy Care Upon Adherence to Cardiovascular Medicines
|
N/A | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Completed |
NCT02753829 -
Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease
|
N/A | |
Recruiting |
NCT01689688 -
Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography
|
N/A | |
Completed |
NCT01779401 -
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
|
N/A | |
Recruiting |
NCT01462799 -
COR-PRIM: Problem-based Learning (PBL) After Coronary Heart Disease (CHD) - Long-term Evaluation in Primary Care of Self-care
|
N/A | |
Recruiting |
NCT01456364 -
Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
|
Phase 4 | |
Completed |
NCT01428947 -
Does Coronary Angiography Cause Cognitive Dysfunction?
|
N/A |